The latest WHO/ECDC report Tuberculosis surveillance and monitoring in Europe 2019 (2017 data) shows that despite an overall decline in numbers of people suffering from TB, the disease remains a major public health challenge in the Region. Of the 275 000 new diagnoses and relapses, an estimated 77 000 people are suffering from difficult-to-treat multidrug-resistant TB (MDR-TB). The European Union and European Economic Area (EU/EEA) countries fare better, with only 1 041 people reported to have MDR-TB. However, most countries in the Region, including many in the EU/EEA, struggle to treat patients successfully.
To read more go to: http://www.euro.who.int/en/media-centre/sections/press-releases/2019/who-europeecdc-joint-press-release-every-hour-30-people-are-diagnosed-with-tuberculosis-tb-in-the-european-region.-its-time-to-make-tb-a-disease-of-the-past?utm_source=WHO%2FEurope+mailing+list&utm_campaign=c77c5422db-News_highlights_January_2018_COPY_01&utm_medium=email&utm_term=0_60241f4736-c77c5422db-93292493
The EU has issued a number of Preparedness Notices, covering a range of issues from car emissions to medicinal products for human use….all are available in English and can be downloaded.
For access to these preparedness notices and for more information on the European Commission website, go to: Preparedness notices | European Commission
Detecting cancer from breath doesn’t sound possible right? Well, SniffPhone is the new cancer screening device that enables early diagnosis of gastric cancer by simply exhaling into your phone.
Currently in its prototype phase, SniffPhone enables early diagnosis of gastric cancer from detecting cancer from breath. This new cancer screening device has the ability to revolutionise cancer screening all over the world.
SniffPhone is a small sensor developed as a cancer screening device that can be attached to a smartphone.
In practice, the user holds the device in front of his or her mouth and exhales onto the sensor to give a breath sample. This test for cancer measures the contained Volatile Organic Compounds (VOCs) using highly sensitive nanotechnology-based chemical sensors.
The measurements are then sent via Bluetooth using a smartphone to a dedicated cloud platform, where they are analysed by the appropriate medical personnel.
The SniffPhone project is financed under the EU’s Horizon 2020 Programme for research, technological development and demonstration. The SniffPhone was developed by a consortium of nine partners from six countries. The nanosensors of the SniffPhone were developed in Israel, the micropump by Cellix in Ireland, fluidics by Microfluidic ChipShop in Germany, and the cloud platform by VTT in Finland.
To read more about this go to: https://www.healtheuropa.eu/cancer-screening-device-detecting-cancer-from-breath/90718/
To support better diagnosis and treatment, the European Commission is launching a new online knowledge-sharing platform for more than 30 million Europeans living with rare diseases.
Rare diseases can affect individuals from birth, like cystic fibrosis, or it can develop later in life, like Huntington’s disease. Regardless of the large total numbers of those affected in Europe, an effective knowledge-sharing platform is not currently available and information on effective diagnosis and treatment strategies are not collected in a uniform way and are often not shared among registries or across countries. As a consequence, patients more than often suffer alone with little or no hope of being cured, but the European Commission is looking to change this.
To read more about this go to: https://www.healtheuropa.eu/european-commission-knowledge-sharing-platform-rare-diseases/90565/
Nine out of ten people worldwide breathe polluted air daily, according to the World Health Organisation (WHO). That means 91% of the world’s population are living in places where air quality exceeds guideline limits.
Air pollution is thought to directly cause the deaths of around 7 million people per year, mostly in Asia and Africa.25% of heart disease, 24% of strokes, and 43% of lung disease and lung cancer deaths could be “attributed to air pollution”, according to WHO.
Cities in India and China accounted for many of the worst culprits, but Europeans are also affected by the phenomenon. Exposure to particulate matter (PM) has decreased the life expectancy of every person on the continent by an average of almost 1 year, mostly due to increased risk of cardiovascular and respiratory diseases, and lung cancer, according to WHO.
The organisation also said that if air pollution in European cities was reduced below the air quality guideline levels, people would live longer — in some cases by almost 2 years.
To read more about this go to: https://www.euronews.com/2019/02/19/air-pollution-knocks-almost-one-year-off-the-average-european-s-life-who
EU certification granted in the U.K. to medical supplies made in other countries could become invalid in the event of a no-deal Brexit, Dutch hospitals group warns.
A no-deal Brexit carries “great risks” to medical supplies in the Netherlands and across the EU, the Dutch Federation of Academic Hospitals (NFU) warned Wednesday.
An “emergency law” has been requested to license the use of U.K.-certified medical supplies until the end of 2019, Reuters reports, amid growing concern that hospitals across the EU could be left without sufficient medical supplies if Britain crashes out of the bloc on March 29 with no deal.
To read more about this, go to: https://www.politico.eu/article/dutch-hospitals-warn-on-medical-supplies-if-theres-a-no-deal-brexit/
Europeans are living longer but the increase in their life expectancy has slowed since 2010, according to a study undertaken by the OECD and supported by the European Commission.
The State of Health in the EU Cycle report, updated every two years, has identified mental health and the health gap between rich and poor as two areas where there remains a particular need for improvement.
The study compares medical data from across all EU countries as well as Norway, Switzerland, Iceland and Turkey. An interactive country-by-country guide shows which are performing above and below the EU average.
To read more about this study on the Euronews website go to: https://www.euronews.com/2018/11/27/eu-health-report-we-re-living-longer-but-the-pay-gap-and-mental-health-still-cause-for-con
Luxembourg topped the EU ranking for highest healthcare expenditure per inhabitant in 2016, spending some €5,600 per head, Eurostat revealed on Thursday.
The latest figures from the EU’s official statistics agency, Eurostat, show that healthcare expenditure per inhabitant was €5,000 or higher in three EU member states in 2016.
Luxembourg was found to be the most generous with €5,600 spend on each of its 590,000 inhabitant. Sweden and Denmark completed the podium, spending €5,100 and €5,000 per capita respectively.
On the other end of the spectrum, the three countries with the lowest healthcare expenditure per head in 2016 were Poland (€700), Bulgaria (€600) and Romania (€400).
It’s worth noting though that Switzerland and Norway, which are not EU member states spent considerably, and would have topped the EU chart.
Source: Here’s how much your country spends on your healthcare | Euronews